12 completed. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 12 |
Follow Malaria, Vivax: new trials by email Literature Review of Malaria, Vivax trials Research Report on Malaria, Vivax
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vivax Elimination With Tafenoquine (VET) Study Tafenoquine - Malaria, Malaria, Vivax | Phase 4 | Completed | Shoklo Malaria Research Unit | 1242 | 2025-02-19 | 2026-01-06 |
| Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax Chloroquine, Primaquine - Efficacy, Malaria | Phase 4 | Completed | Dinka Dugassa | 100 | 2022-12-19 | 2023-09-22 |
| Short Course Radical Cure of P. Vivax Malaria in Nepal primaquine - Malaria, Malaria, Vivax | Phase 4 | Completed | Menzies School of Health Research | 27 | 2021-10-27 | 2024-08-29 |
| Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure Primaquine, Artesunate - Vivax Malaria | Phase 4 | Completed | University of Maryland, Baltimore | 160 | 2021-04-15 | 2026-06-03 |
| Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas primaquine - Malaria, Vivax Malaria | Phase 4 | Completed | Menzies School of Health Research | 500 | 2019-08-18 | 2023-11-21 |
| G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria Chloroquine, Primaquine 0.25 mg/kg/day, Primaquine 0.75 mg/kg weekly - Vivax Malaria | Phase 4 | Completed | University of Oxford | 1000 | 2016-09-01 | 2020-10-14 |
| Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia: Chloroquine sulfate, DHA-PP - Vivax Malaria | Phase 4 | Completed | Institut Pasteur, Cambodia | 73 | 2014-05-01 | 2015-03-24 |
| Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam Chloroquine, Dihydroartemisinin/Piperaquine - Plasmodium Vivax Malaria | Phase 4 | Completed | Oxford University Clinical Research Unit, Vietnam | 330 | 2013-02-01 | 2016-09-30 |
| Ethiopia Antimalarial in Vivo Efficacy Study 2012 Artemether-lumefantrine combination, Primaquine, Chloroquine - Plasmodium Vivax Infection | Phase 4 | Completed | Centers for Disease Control and Prevention | 398 | 2012-10-01 | 2017-01-19 |
| Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity Primaquine, Placebo, Chloroquine - Plasmodium Vivax Infection, Plasmodium Vivax Clinical Episode | Phase 4 | Completed | Papua New Guinea Institute of Medical Research | 524 | 2009-08-01 | 2014-05-21 |
| Estimating the Risk of Plasmodium Vivax Relapses in Afghanistan Chloroquine, Chloroquine/Primaquine - Vivax Malaria | Phase 4 | Completed | University of Oxford | 593 | 2009-08-01 | 2019-01-15 |
| Effectiveness of Malaria Treatment in Mexico Chloroquine phosphate, primaquine - Malaria | Phase 4 | Completed | LILIA GONZALEZ CERON | 153 | 2008-02-01 | 2015-03-20 |
Malaria (8) · Malaria, Falciparum (3) · Recurrence (1)
Infections (12) · Mosquito-Borne Diseases (12) · Parasitic Diseases (12) · Protozoan Infections (12) · Vector Borne Diseases (12) · Malaria (4) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Primaquine (9) · Chloroquine (8) · Artemether, Lumefantrine Drug Combination (2) · chloroquine diphosphate (2) · 2,6-diisopropylphenol docosahexaenoate (1) · Artesunate (1) · artenimol (1) · piperaquine (1) · tafenoquine (1)
Menzies School of Health Research (2) · University of Oxford (2) · Centers for Disease Control and Prevention (1) · Dinka Dugassa (1) · Institut Pasteur, Cambodia (1) · LILIA GONZALEZ CERON (1) · Oxford University Clinical Research Unit, Vietnam (1) · Papua New Guinea Institute of Medical Research (1) · Shoklo Malaria Research Unit (1) · University of Maryland, Baltimore (1)
Ethiopia (3) · Afghanistan (2) · Cambodia (2) · Bangladesh (1) · Indonesia (1) · Nepal (1) · Papua New Guinea (1) · Thailand (1) · Vietnam (1)
Bockretsion Gidey (1) · David Hoos, MD MPH (1) · Dysoley Lek, MD (1) · Ghulam Rahim Awab, MD (1) · Inoni Betuela, MD PhD (1) · Ivo Mueller, PhD (1) · Jean Popovici, PhD (1) · Jimee Hwang, MD MPH (1) · Kamala Ley-Thriemer, MD, PhD (1) · Kamala Thriemer, MD (1) · Louis Schofield, PhD (1) · Tesfay Abreha, MSc, MPH (1)
PMID 22531245, PMID 23212366, PMID 26505753, PMID 26518132, PMID 28510573, PMID 28732068, PMID 28862132, PMID 29362233, PMID 29398388, PMID 30698522, PMID 33299558, PMID 33552517, PMID 34336132, PMID 35585641, PMID 36099312, PMID 36534705, PMID 37790581, PMID 37979594, PMID 38115002, PMID 39802788, PMID 40112852, PMID 40764298, PMID 42033147, PMID 42439801
R01AI103228 (1)